{"url_path":"/sec/palx/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1938569/0001493152-26-023678-index.html","accession_number":"0001493152-26-023678","cik":"0001938569","ticker":"PALX","issuer_name":"Palomino Laboratories Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1938569/0001493152-26-023678-index.html","primary_entity_key":"0001938569","primary_entity_name":"Palomino Laboratories Inc."},"word_count":714,"has_tables":true,"body_markdown":"false\nQ1\n--12-31\n0001938569\n\n0001938569\n\n2026-01-01\n2026-03-31\n\n0001938569\n\n2026-05-15\n\n0001938569\n\n2026-03-31\n\n0001938569\n\n2025-12-31\n\n0001938569\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nus-gaap:CommonStockMember\n\n2025-12-31\n\n0001938569\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-12-31\n\n0001938569\n\nus-gaap:RetainedEarningsMember\n\n2025-12-31\n\n0001938569\n\nus-gaap:CommonStockMember\n\n2023-12-31\n\n0001938569\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2023-12-31\n\n0001938569\n\nus-gaap:RetainedEarningsMember\n\n2023-12-31\n\n0001938569\n\n2023-12-31\n\n0001938569\n\nus-gaap:CommonStockMember\n\n2024-12-31\n\n0001938569\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-12-31\n\n0001938569\n\nus-gaap:RetainedEarningsMember\n\n2024-12-31\n\n0001938569\n\n2024-12-31\n\n0001938569\n\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nus-gaap:RetainedEarningsMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nus-gaap:CommonStockMember\n\n2024-01-01\n2024-12-31\n\n0001938569\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-01-01\n2024-12-31\n\n0001938569\n\nus-gaap:RetainedEarningsMember\n\n2024-01-01\n2024-12-31\n\n0001938569\n\n2024-01-01\n2024-12-31\n\n0001938569\n\n2024-01-01\n2025-12-31\n\n0001938569\n\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nus-gaap:RetainedEarningsMember\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0001938569\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-03-31\n\n0001938569\n\nus-gaap:RetainedEarningsMember\n\n2026-03-31\n\n0001938569\n\nus-gaap:CommonStockMember\n\n2025-03-31\n\n0001938569\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-03-31\n\n0001938569\n\nus-gaap:RetainedEarningsMember\n\n2025-03-31\n\n0001938569\n\n2025-03-31\n\n0001938569\n\n2025-09-29\n\n0001938569\n\nus-gaap:SubsequentEventMember\n\n2026-04-01\n2026-04-30\n\n0001938569\n\nsrt:MinimumMember\n\n2026-03-31\n\n0001938569\n\nsrt:MaximumMember\n\n2026-03-31\n\n0001938569\n\nPALX:UnvestedRestrictedStockAwardsMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nPALX:UnvestedRestrictedStockAwardsMember\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nus-gaap:OptionMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nus-gaap:OptionMember\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nus-gaap:WarrantMember\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nPALX:GeneralAndAdministrativeExpensesMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nPALX:GeneralAndAdministrativeExpensesMember\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nPALX:ResearchAndDevelopmentsExpensesMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nPALX:ResearchAndDevelopmentsExpensesMember\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nus-gaap:EquipmentMember\n\n2026-03-31\n\n0001938569\n\nus-gaap:EquipmentMember\n\n2025-12-31\n\n0001938569\n\nus-gaap:ConstructionInProgressMember\n\n2026-03-31\n\n0001938569\n\nus-gaap:ConstructionInProgressMember\n\n2025-12-31\n\n0001938569\n\nPALX:DaltonDenBaarsMember\n\n2025-10-15\n2025-10-15\n\n0001938569\n\nPALX:DaltonDenBaarsMember\n\n2026-03-31\n\n0001938569\n\nPALX:DaltonDenBaarsMember\n\n2025-12-31\n\n0001938569\n\nPALX:DaltonDenBaarsMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nPALX:DaltonDenBaarsMember\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nPALX:StevenDenbaarsMember\n\n2026-03-31\n\n0001938569\n\nPALX:StevenDenbaarsMember\n\n2025-12-31\n\n0001938569\n\nPALX:StevenDenbaarsMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nPALX:StevenDenbaarsMember\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nPALX:ConsultingAgreementMember\n\n2025-10-01\n2025-10-01\n\n0001938569\n\nPALX:ConsultingAgreementMember\nPALX:MsHonickMember\n\n2025-10-01\n2025-10-01\n\n0001938569\n\nPALX:ConsultingAgreementMember\nsrt:ChiefExecutiveOfficerMember\n\n2025-01-01\n2025-01-31\n\n0001938569\n\nPALX:ConsultingAgreementMember\nPALX:MsNguyenMember\n\n2025-10-01\n2025-10-01\n\n0001938569\n\nPALX:ConsultingAgreementMember\nPALX:MsNguyenMember\n\n2025-01-01\n2025-12-31\n\n0001938569\n\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001938569\n\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nPALX:TwoThousandTwentyFiveEquityIncentivePlanMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nus-gaap:RestrictedStockUnitsRSUMember\nPALX:ConsultantsMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nPALX:RestrictedStockAwardsMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nus-gaap:ResearchAndDevelopmentExpense\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nus-gaap:SellingGeneralAndAdministrativeExpense\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nus-gaap:SellingGeneralAndAdministrativeExpense\n\n2025-01-01\n2025-03-31\n\n0001938569\n\nus-gaap:RestrictedStockMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nus-gaap:StockOptionMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nPALX:ConsultantsMember\n\n2026-01-01\n2026-03-31\n\n0001938569\n\nus-gaap:RestrictedStockUnitsRSUMember\nPALX:ConsultantsMember\n\n2025-12-31\n\n0001938569\n\nus-gaap:RestrictedStockUnitsRSUMember\nPALX:ConsultantsMember\n\n2026-03-31\n\n0001938569\n\nus-gaap:SubsequentEventMember\nPALX:SubscriptionAgreementMember\n\n2026-04-24\n2026-04-24\n\n0001938569\n\nus-gaap:SubsequentEventMember\nPALX:SubscriptionAgreementMember\n\n2026-04-24\n\n0001938569\n\nus-gaap:SubsequentEventMember\nPALX:SubscriptionAgreementMember\nus-gaap:InvestorMember\n\n2026-04-30\n2026-04-30\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\nutr:sqft\n\nxbrli:pure\n\n \n\n \n\n** **\n\n**UNITED\nSTATES**\n\n**SECURITIES\nAND EXCHANGE COMMISSION**\n\n**WASHINGTON,\nD.C. 20549**\n\n \n\n**FORM\n10-Q**\n\n \n\n**☒\nQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.**\n\n \n\n**For\nthe Quarterly Period Ended March 31, 2026**\n\n \n\n**or**\n\n \n\n**☐\nTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.**\n\n \n\n**Commission\nFile Number: 000-56582**\n\n** **\n\n**PALOMINO\nLABORATORIES INC.**\n\n(Exact\nname of registrant as specified in its charter)\n\n \n\n**Delaware**\n \n**88-1619619**\n\n(State or other jurisdiction\nof\n \n(I.R.S. Employer\n\nincorporation or organization)\n \nIdentification No.)\n\n \n\n**130 Castilian\nDrive, Suite 102**\n \n \n\n**Goleta, CA**\n \n**93117**\n\n(Address of principal executive\noffices)\n \n(Zip Code)\n\n \n\n**(704)\n756-2981**\n\n****\n\n****\n\n \n\n****\n\n(Registrant’s\ntelephone number, including area code)\n\n \n\nSecurities\nregistered pursuant to Section 12(b) of the Act:\n\n \n\n**Title of\neach class**\n \n**Trading Symbol(s)**\n \n**Name of each\nexchange on which registered**\n\nNone\n \nN/A\n \nN/A\n\n \n\nIndicate\nby check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange\nAct of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2)\nhas been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\n \n\nIndicate\nby check mark whether the registrant has submitted electronically every Interactive Data File to be submitted posted pursuant to Rule\n405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant\nwas required to submit such files). Yes ☒ No ☐\n\n \n\nIndicate\nby check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting\ncompany filer. See definition of “large, accelerated filer,” “accelerated filer,” “smaller reporting company,”\nand “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated\nfiler\n☐\nAccelerated\nfiler\n☐\n\nNon-accelerated Filer\n☒\nSmaller reporting company\n☒\n\n \n \nEmerging growth company\n☒\n\n \n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate\nby check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No\n☒\n\n \n\nAs\nof May 15, 2026, the registrant had 23,164,539 shares of common stock issued and outstanding.\n\n \n\n \n\n \n\n \n\n \n\n \n\n**PALOMINO\nLABORATORIES INC.**\n\n \n\n**QUARTERLY\nREPORT ON FORM 10-Q**\n\n \n\n**March\n31, 2026**\n\n \n\n**TABLE\nOF CONTENTS**\n\n \n\n \n \nPage\n\n \n \n \n\n[PART I – FINANCIAL INFORMATION](#VM_001)"}